Pirenoxine sodium eye drops
Function and Efficacy
Studies have shown that one of the causes of cataract formation is that soluble proteins in the lens are gradually transformed into insoluble proteins by the action of quinones. Quinones are formed by the abnormal metabolism of tryptophan, an important functional amino acid in the body. The effect of such quinones on soluble proteins in the lens can be competitively inhibited by pyrenoxetine sodium. In addition, pyrenoxetine sodium can also fight against cataracts caused by free radical damage to the lens. Therefore, this product has a certain inhibitory effect on the development of cataracts. Animal experiments have shown that pyrenoxetine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction.
Ingredients
Main ingredient: Sodium pyrenoxine. Its chemical name is: 1-hydroxy-5-oxo-5H-pyrido-[3,2-]-phenoxazine-3-carboxylate sodium (monohydrate) Molecular formula: C16H7N2NaO5H2O Molecular weight: 348.25
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| 1-HYDROXY-5-OXO-5H-PYRIDO[3,2-A]PHENOXAZINE-3-CARBOXYLIC ACID MONOSODIUM SALTIngredients |
Pirenoxine sodium can competitively inhibit the effect of quinone substances on lens soluble proteins, and can also fight against cataracts caused by free radical damage to the lens, and has a certain inhibitory effect on the development of cataracts. Animal experiments have shown that pirenoxine sodium can reduce the incidence of posterior capsule opacity after extracapsular cataract extraction. More |
51410-30-1 | 6 |
Appearance
This product is light yellow or orange-yellow liquid.
Indication
It is mainly used to treat early senile cataracts, mild diabetic cataracts or complicated cataracts.
Usage and Dosage
Apply in eyes, 3 to 4 times a day, 1 to 2 drops each time.
Adverse Reactions
Very few patients may experience mild eye pain.
Precautions
Do not use in case of eye injury or severe infection, or follow doctor's advice.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear.
Storage
Keep away from light and stored in a sealed place.
Packaging Specification
15 ml: 0.8 mg
Validity Period
24 months
Manufacturer
Wuhan Wujing Pharmaceutical Co., Ltd.
-
Founded in:
2001-12-30 -
Address:
No. 2, Jinyinhu South Third Street, Jinyinhu Office, Dongxihu District, Wuhan -
Tax NO.:
91420000177568347U -
Registered Funds:
30 million yuan -
Website:
-
Email: